Actively Recruiting
Artificial Intelligence-Based Assessment of Endosseous Lesions: A Prospective Clinical Study
Led by University of Bari Aldo Moro · Updated on 2026-04-15
10
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial evaluates the use of Artificial Intelligence (AI) to analyze endosseous lesions in patients with maxillary or mandibular cysts. Traditional interpretation of cone beam computed tomography (CBCT) scans relies on qualitative and experience-dependent methods, which may underestimate lesion complexity. The study aims to compare AI-based segmentation and volumetric analysis with conventional CBCT interpretation to assess potential improvements in lesion evaluation and clinical outcomes. Participants will be randomly assigned to either receive conventional CBCT evaluation or AI-assisted evaluation of their scans. The AI tool performs automated segmentation of the lesion, 3D reconstruction, and volumetric calculation to provide objective and reproducible measurements. This approach seeks to enhance surgical planning, predict anatomical involvement, reduce diagnostic errors, and standardize follow-up assessments. During the study, researchers will measure the time required for CBCT interpretation and monitor intraoperative and postoperative complications. Participants will undergo evaluations on day 1, including scan analysis and clinical assessments. The study involves adults aged 18 to 80 years in good health, with no contraindications for surgery, and will continue until May 2026.
CONDITIONS
Brief Title
Artificial Intelligence-Based Assessment of Endosseous Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Good health according to the System of the American Society of Anesthesiology
- Aged older than 18 years
- No general medical contraindication for surgery
You will not qualify if you...
- Smoking more than 15 cigarettes a day
- Pregnancy
- Acute infections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day 1
Participants undergo CBCT scans which are assessed either conventionally or with AI-assisted software for lesion segmentation, 3D reconstruction, and volumetric calculation.
1 visit (in-person)
Trial Site Locations
Total: 2 locations
1
University of Bari Aldo Moro
Bari, Italy, 70021
Actively Recruiting
2
Dr. Giuseppe D'Albis
Bari, Italy, 70124
Actively Recruiting
Research Team
G
Giuseppe D'Albis, Dr.
S
Saverio Capodiferro, Prof.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here